Leveraging Purigen's ITP-based extraction @ MD Anderson Cancer Center
1 Sept 2022
ABRF 2022 Technology Showcase with special guest speaker Dr. Jian Gu from the University of Texas, MD Anderson Cancer Center. This video discusses how the next-gen Ionic® Purification System enables pure nucleic acid extraction from FFPE samples using our proprietary charge-based isotachophoresis (ITP) technology.
About the company
Purigen Biosystems
Purigen Biosystems' transformative Ionic Purification System provides a hands-free solution for extracting, enriching and quantifying DNA and RNA from biological samples. Our proprietary approach uses isotachophoresis (ITP), an electric-field-driven technique for purifying, focusing, and/or separating species. The application of ITP to purify and quantify nucleic acids from complex biological samples was pioneered by Purigen co-founder, Stanford Professor Juan G. Santiago. The Ionic® Purification System is compatible with a range of samples including cells and FFPE. Purigen is proudly affliated with StartX Med, a Stanford-University-affliated nonprofit technology accelerator, and the California Life Sciences Institute’s (CLSI) FAST Advisory Program.





